Primary Hyperoxaluria Type 1 Latest Advances

Novel AAV843 Vector-Mediated Gene Replacement Therapy Rescues Primary Hyperoxaluria Type I in Mice.

Journal: Cells

Published: February 13, 2026

Don't think that combined liver kidney transplant can solve everything in primary hyperoxaluria type 1!

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: January 13, 2026

Targeting Oxalate Production by Combining Enzyme Inhibition and Proteolysis Activation: A Novel Therapeutic Approach for Primary Hyperoxaluria Type 1.

Journal: Journal of medicinal chemistry

Published: January 02, 2026

The Dawn of Precision Medicine in Pediatric Nephrology: Lumasiran and the Era of siRNA Therapies for Primary Hyperoxaluria Type 1.

Journal: Journal of personalized medicine

Published: November 24, 2025

Natural History of Advanced Primary Hyperoxaluria Type 1: A Retrospective Study.

Journal: Kidney medicine

Published: November 10, 2025

Current status of primary hyperoxaluria type 1 in Japan.

Journal: Urolithiasis

Published: October 19, 2025

Genomic testing in pediatric urology: Implications for diagnosis and management.

Journal: Journal of pediatric urology

Published: October 08, 2025

A Case of Successful Kidney Transplant-Alone in Primary Hyperoxaluria Type 1 Using Lumasiran.

Journal: Clinical transplantation

Published: September 23, 2025

Surgical Management of Pediatric Primary Hyperoxaluria Type 1: An Eight-Patient Case Series in the Pre-siRNA Era.

Journal: Pediatric transplantation

Published: September 20, 2025

LNP-mediated in vivo base editing corrects Agxt to cure primary hyperoxaluria type 1.

Journal: Clinical and translational medicine

Published: July 18, 2025

Genetic Insights Into Nephrolithiasis and Renal Cancer Predisposition: Precision Medicine in Genes, Diagnosis, and Therapy.

Journal: Seminars in nephrology

Published: July 15, 2025

Primary hyperoxaluria: insights into its clinical presentation, genetic mutations, and transplantation outcomes in a pediatric population in a tertiary care center.

Journal: Orphanet journal of rare diseases

Published: June 25, 2025

Primary Hyperoxaluria Type 1 Latest Advances

Find the Latest Research About Primary Hyperoxaluria Type 1

Novel AAV843 Vector-Mediated Gene Replacement Therapy Rescues Primary Hyperoxaluria Type I in Mice.

Novel AAV843 Vector-Mediated Gene Replacement Therapy Rescues Primary Hyperoxaluria Type I in Mice.

Don't think that combined liver kidney transplant can solve everything in primary hyperoxaluria type 1!

Don't think that combined liver kidney transplant can solve everything in primary hyperoxaluria type 1!

Targeting Oxalate Production by Combining Enzyme Inhibition and Proteolysis Activation: A Novel Therapeutic Approach for Primary Hyperoxaluria Type 1.

Targeting Oxalate Production by Combining Enzyme Inhibition and Proteolysis Activation: A Novel Therapeutic Approach for Primary Hyperoxaluria Type 1.

The Dawn of Precision Medicine in Pediatric Nephrology: Lumasiran and the Era of siRNA Therapies for Primary Hyperoxaluria Type 1.

The Dawn of Precision Medicine in Pediatric Nephrology: Lumasiran and the Era of siRNA Therapies for Primary Hyperoxaluria Type 1.

Natural History of Advanced Primary Hyperoxaluria Type 1: A Retrospective Study.

Natural History of Advanced Primary Hyperoxaluria Type 1: A Retrospective Study.

Current status of primary hyperoxaluria type 1 in Japan.

Current status of primary hyperoxaluria type 1 in Japan.

Genomic testing in pediatric urology: Implications for diagnosis and management.

Genomic testing in pediatric urology: Implications for diagnosis and management.

A Case of Successful Kidney Transplant-Alone in Primary Hyperoxaluria Type 1 Using Lumasiran.

A Case of Successful Kidney Transplant-Alone in Primary Hyperoxaluria Type 1 Using Lumasiran.

Surgical Management of Pediatric Primary Hyperoxaluria Type 1: An Eight-Patient Case Series in the Pre-siRNA Era.

Surgical Management of Pediatric Primary Hyperoxaluria Type 1: An Eight-Patient Case Series in the Pre-siRNA Era.

LNP-mediated in vivo base editing corrects Agxt to cure primary hyperoxaluria type 1.

LNP-mediated in vivo base editing corrects Agxt to cure primary hyperoxaluria type 1.

Genetic Insights Into Nephrolithiasis and Renal Cancer Predisposition: Precision Medicine in Genes, Diagnosis, and Therapy.

Genetic Insights Into Nephrolithiasis and Renal Cancer Predisposition: Precision Medicine in Genes, Diagnosis, and Therapy.

Primary hyperoxaluria: insights into its clinical presentation, genetic mutations, and transplantation outcomes in a pediatric population in a tertiary care center.

Primary hyperoxaluria: insights into its clinical presentation, genetic mutations, and transplantation outcomes in a pediatric population in a tertiary care center.